What are the consequences of untreated ankylosing spondylitis in a young to middle-aged male patient with a potential family history of the disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Consequences of Untreated Ankylosing Spondylitis

Untreated ankylosing spondylitis leads to progressive structural damage with irreversible spinal fusion, severe functional disability, and substantially diminished quality of life, making early diagnosis and treatment essential to prevent these devastating outcomes. 1

Progressive Structural Damage and Deformity

Untreated AS causes relentless progression of spinal inflammation leading to new bone formation, vertebral fusion, and fixed kyphotic deformity. 1 The disease process results in:

  • Complete spinal ankylosis with loss of all spinal mobility, creating a rigid "bamboo spine" that severely restricts movement 2, 3
  • Severe thoracolumbar kyphosis that can progress to the point where patients literally look at the floor rather than forward, losing horizontal vision entirely 1, 2
  • Sacroiliac joint fusion with radiographic sacroiliitis developing over several years of untreated inflammation 3, 4
  • Hip joint destruction requiring total hip arthroplasty in patients with refractory pain and structural damage 1

Functional Impairment and Disability

The physical consequences of untreated AS are profound and life-altering:

  • Loss of work productivity with high rates of work disability and unemployment, ranking AS second among "great rheumatic diseases" leading to considerable disability 3, 5
  • Inability to perform basic self-care activities due to limited motoric function, making full self-functioning impossible in advanced cases 5
  • Cardiopulmonary compromise from severe kyphosis causing intra-abdominal pressure and restricted chest expansion 1
  • Loss of horizontal vision in severe kyphosis, requiring patients to compensate by tilting their entire body to see forward 1

Quality of Life Deterioration

Patients with untreated AS experience severe degradation across all life domains—physical, psychological, environmental, and social. 5

  • Chronic unrelenting pain that worsens at night and in the morning, with inflammatory back pain persisting throughout the disease course 3, 4
  • Profound psychological impact including depression, apathy, and discouragement from undertaking treatment, with patients reporting severe dissatisfaction with their health quality 5
  • Social isolation particularly affecting those living alone or in rural areas who lack adequate support systems 5
  • Reduced life expectancy and increased morbidity from extra-articular manifestations and complications 1

Extra-Articular Complications

Untreated AS extends beyond the spine with systemic manifestations:

  • Acute anterior uveitis requiring urgent ophthalmologic treatment to prevent vision loss 1, 3
  • Aortic regurgitation and other cardiac complications from chronic inflammation 3, 4
  • Inflammatory bowel disease associations that compound disability 3
  • Enthesitis at multiple sites causing additional pain and functional limitation 1

Increased Surgical Risk and Complications

When disease progresses untreated to the point requiring surgery, outcomes are significantly worse:

  • Spinal fractures in the fused ankylosed spine carry 16-29% mortality rates in some surgical series 1
  • Permanent neurological complications occur in up to 5% of corrective osteotomy procedures for severe kyphosis 1
  • Instrumentation failure reported in up to 33% of cases requiring spinal correction 1
  • Perioperative mortality of 4% for elective spinal osteotomy in advanced disease 1

The Critical Window for Intervention

The key distinction is that early treatment can prevent structural damage and preserve function, while delayed treatment can only manage symptoms in an already damaged spine. 1

  • Control of inflammation early in disease is essential to prevent the irreversible new bone formation that characterizes AS 1
  • NSAIDs as first-line treatment show large effects on spinal pain and moderate benefit for physical function when started early 1, 6
  • TNF inhibitors for active disease demonstrate rapid effectiveness in reducing symptoms, slowing progression, and improving function when conventional treatment fails 6, 3
  • Combination of pharmacological and non-pharmacological treatment including physical therapy is essential from disease onset 1

Common Pitfalls in Untreated Disease

The insidious onset and diagnostic delay of AS—often several years before radiological sacroiliitis appears—means many patients suffer irreversible damage before diagnosis. 3, 4

  • Misdiagnosis as mechanical back pain or other conditions delays appropriate treatment, as illustrated by cases initially diagnosed as sacroiliac dysfunction or stress fractures 4
  • Undertreatment due to diagnostic delay allows inflammation to progress unchecked during the critical early disease period 6, 3
  • Failure to recognize inflammatory back pain patterns (worse at night/morning, improves with activity) leads to missed diagnoses in young males aged 15-30 years 3, 4

The evidence unequivocally demonstrates that AS is a potentially severe, progressive disease requiring early rheumatologic intervention to maximize long-term health-related quality of life and prevent the devastating structural damage and disability that characterize untreated disease. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ankylosing spondylitis: an overview.

Annals of the rheumatic diseases, 2002

Research

[Quality of life of patients with ankylosing spondylitis].

Annales Academiae Medicae Stetinensis, 2006

Research

Treatment of ankylosing spondylitis.

The Journal of rheumatology. Supplement, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.